Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of point-of-care anticoagulation monitoring in arterial and venous thromboembolic disorders.

× No keyword cloud information.

33 in total

1. Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times.

Authors: J Ansell; A Holden; N Knapic
Journal: Arch Intern Med Date: 1989-11

2. Bedside heparin monitoring by activated partial thromboplastin time measured with a dry reagent.

Authors: R Linder; L Grip; E Olason; M Blombäck
Journal: Clin Chem Date: 1996-09 Impact factor: 8.327

3. Intraoperative measurement of activated partial thromboplastin time and prothrombin time with a new compact monitor.

Authors: C M Samama; R Quezada; B Riou; E Mourgeon; M Arock; A Ankri; P Viars
Journal: Acta Anaesthesiol Scand Date: 1994-04 Impact factor: 2.105

4. The effect of oral anticoagulant therapy on APTT results from a bedside coagulation monitor.

Authors: M J Ray; P A Carroll; S J Just; G A Hawson; J H Bett
Journal: J Clin Monit Date: 1994-03

5. A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators.

Authors: R C Becker; S P Ball; P Eisenberg; S Borzak; A C Held; F Spencer; S J Voyce; R Jesse; R Hendel; Y Ma; T Hurley; J Hebert
Journal: Am Heart J Date: 1999-01 Impact factor: 4.749

6. Effect of analytic uncertainty of conventional and point-of-care assays of activated partial thromboplastin time on clinical decisions in heparin therapy.

Authors: M Werner; J V Gallagher; M S Ballo; D S Karcher
Journal: Am J Clin Pathol Date: 1994-08 Impact factor: 2.493

7. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.

Authors: G J Despotis; S A Santoro; E Spitznagel; K M Kater; P Barnes; J L Cox; D G Lappas
Journal: Anesthesiology Date: 1994-02 Impact factor: 7.892

8. Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: a coronary care unit experience.

Authors: R C Becker; J Cyr; J M Corrao; S P Ball
Journal: Am Heart J Date: 1994-10 Impact factor: 4.749

9. Cost effectiveness of monitoring warfarin therapy using standard versus capillary prothrombin times.

Authors: J E Ansell; A K Hamke; A Holden; N Knapic
Journal: Am J Clin Pathol Date: 1989-05 Impact factor: 2.493

10. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor.

Authors: P Massicotte; V Marzinotto; P Vegh; M Adams; M Andrew
Journal: J Pediatr Date: 1995-09 Impact factor: 4.406

1 in total

1. Monitoring Anticoagulation with Unfractionated Heparin on Renal Replacement Therapy. Which is the Best aPTT Sampling Site?

Authors: Florin Ioan Anton; Paul Adrian Rus; Natalia Hagau
Journal: J Crit Care Med (Targu Mures) Date: 2020-08-11

1 in total